Marin M Jukic

6PUBLICATIONS
39CO-AUTHORS
PharmacogenomicsCancer geneticsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Neural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 22, 2025
Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into Account.

Inger Johansson, Emmanouella M Xanthopoulou, Yitian Zhou

|Jun 24, 2024
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics.

Xenia Marlene Hart, Gerhard Gründer, Nicolas Ansermot

|Nov 20, 2023
What is the Current Clinical Impact of the CYP2CTG Haplotype?

Magnus Ingelman-Sundberg, Marin Jukic, Line Skute Bråten

|Sep 24, 2022
Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits.

Hasan Çağın Lenk, Robert Løvsletten Smith, Kevin S O'Connell

|Mar 07, 2022
The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients.

Hasan Çağın Lenk, Katharina Klöditz, Inger Johansson

|Jan 12, 2018
BMP/SMAD Pathway Promotes Neurogenesis of Midbrain Dopaminergic Neurons In Vivo and in Human Induced Pluripotent and Neural Stem Cells.

Vukasin M Jovanovic, Ahmad Salti, Hadas Tilleman

Pageof 1

Frequent Collaborators

4 joint publications

Magnus Ingelman-Sundberg

4 joint publications

Espen Molden

2 joint publications

Hasan Çağın Lenk

2 joint publications

Robert Løvsletten Smith